Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Tesaro Inc (TSRO)

Tesaro Inc (TSRO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,126,323
  • Shares Outstanding, K 55,047
  • Annual Sales, $ 223,330 K
  • Annual Income, $ -496,130 K
  • 60-Month Beta 0.38
  • Price/Sales 18.69
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -11.86
  • Most Recent Earnings -2.49 on 11/01/18
  • Next Earnings Date 02/26/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -2.45
  • Number of Estimates 9
  • High Estimate -2.28
  • Low Estimate -2.89
  • Prior Year -3.35
  • Growth Rate Est. (year over year) +26.87%

Price Performance

See More
Period Period Low Period High Performance
1-Month
72.59 +3.26%
on 12/21/18
75.16 -0.27%
on 12/28/18
+1.50 (+2.04%)
since 12/18/18
3-Month
23.41 +220.21%
on 11/09/18
75.16 -0.27%
on 12/28/18
+31.98 (+74.41%)
since 10/18/18
52-Week
23.41 +220.21%
on 11/09/18
75.16 -0.27%
on 12/28/18
+11.46 (+18.05%)
since 01/18/18

Most Recent Stories

More News
Actor Scott Foley and TESARO Team Up to Empower Ovarian Cancer Care Partners Through New Phase of Not on My Watch Movement

TESARO, Inc., an oncology-focused business within GSK, announced today that acclaimed actor Scott Foley (TV's Felicity, Scandal and the new ABC series, Whiskey Cavalier) has joined the nationwide Not on...

TSRO : 74.96 (+0.03%)
TESARO, Inc. Provides Notice of Fundamental Change, Conversion Rate Adjustment pursuant to Make-Whole Adjustment Event and Supplemental Indenture

TESARO, Inc. (the "Company" or "TESARO"), an oncology-focused biopharmaceutical company, today announced that pursuant to the terms of the Indenture and the First Supplemental Indenture to the Indenture...

TSRO : 74.96 (+0.03%)
The Government Won't Let Huawei Enforce U.S. Patents

The government is not in the mood for talks with the Chinese telecom giant.

VZ : 61.05 (+1.06%)
TMUS : 81.60 (+0.68%)
GOGO : 5.86 (-2.74%)
USM : 36.33 (+0.08%)
GLIBA : 66.41 (+0.85%)
NE Farmers Seeing Delayed Wheat Progress Compared to Average Pace

Another Day, Another Tariff

The 5% tariff scheduled to take effect on all Mexican imports to the U.S. June 1st is just the beginning.

South Carolina Farmers Market - Columbia, SC

COLUMBIA, SC Tuesday, June 18, 2019 South Carolina State Farmers Market - Prices to Growers Provided by: Specialty Crops Market News Federal State Market News Office Columbia, SC CA_FV001 Columbia...

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade TSRO with:

Business Summary

Tesaro, Inc. is an oncology-focused biopharmaceutical company for cancer patients. The Company's product portfolio consists of Rolapitant, a neurokinin-1 receptor antagonist for the prevention of chemotherapy induced nausea and vomiting, TSR-011, an orally available anaplastic lymphoma kinase inhibitor...

See More

Key Turning Points

2nd Resistance Point 74.99
1st Resistance Point 74.97
Last Price 74.96
1st Support Level 74.94
2nd Support Level 74.93

See More

52-Week High 75.16
Last Price 74.96
Fibonacci 61.8% 55.39
Fibonacci 50% 49.29
Fibonacci 38.2% 43.18
52-Week Low 23.41

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar